Ajinomoto Co., Inc. · TSE:2802

Ajinomoto — Q2 FY2014 Earnings Presentation

40 slides from Ajinomoto's earnings presentation, Nov 10, 2014

  1. Slide 1: Forecast for the Fiscal Year Ending March 31, 2015 (FY2014) and Outlook

    Ajinomoto Co., Inc.(2802) Forecast for the Fiscal Year Ending March 31, 2015 (FY2014) and Outlook November 10, 2014 Masatoshi Ito President & CEO

  2. Slide 2: Contents

    Contents I. Overview of FY2014 Forecast FY2014 Forecast ・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・2 Impact of External Environment on FY2014 Operating Income ・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・3 FY2014 Forecast by Segment ・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・4 FY2014 Forecast - Ordinary Income and Net

  3. Slide 3: I. Overview of FY2014 Forecast

    I. Overview of FY2014 Forecast Copyright © 2014 Ajinomoto Co., Inc. All rights reserved.

  4. Slide 4: FY2014 Forecast

    FY2014 Forecast No change in Groupwide net sales, operating income or net income forecast from the beginning of FY2014. Operating income has been revised downward for pharmaceuticals and revised upward for overseas food products. (\ Billion) FY2014 FY2013 YoY Note: Net sales are based on a new stand

  5. Slide 5: Impact of External Environment on FY2014 Operating Income

    Impact of External Environment on FY2014 Operating Income Assumed exchange rates are unchanged from the beginning of FY2014. Regarding fermentation raw material and fuel prices, main raw materials, sub raw materials and energy are all expected to improve substantially from the forecast at the beginn

  6. Slide 6: FY2014 Forecast by Segment

    FY2014 Forecast by Segment (¥ Billion) FY2014 FY2014 FY2013 YoY Change Revised Forecast OP% Initial Forecast OP% Difference OP% Amount % Results (A) (B) (A)-(B) (A)/(B) Net sales 1,008.0 1,008.0 0.0 951.4 56.6 6% Domestic Food Products 312.3 312.3 0.0 299.9 12.4 4% Overseas Food Products 322.2 322.2

  7. Slide 7: FY2014 Forecast - Ordinary Income and Net Income

    FY2014 Forecast - Ordinary Income and Net Income No change in forecast for either extraordinary gains (losses) or net income from beginning of FY2014. FY2014 FY2013 Difference Main Factors Forecast Results Net sales 1,008.0 951.4 56.6 Net sale s based on new standard from FY2 014 Operating income 70

  8. Slide 8: Targeted Composition of Operating Income

    Targeted Composition of Operating Income Raise earnings quality by controlling the ratio of bulk businesses and pursuing specialty Groupwide. (¥ Billion) Feed-use amino acids 150.0 150.0 Pharmaceuticals 10.0 Calpis 9.0 (until FY2012) 91.0 8.0 Food Products, Bioscience Products 4.6 and Fine Chemicals

  9. Slide 9: Roadmap to a Genuine Global Specialty Company

    Roadmap to a Genuine Global Specialty Company Accelerate growth to take aim at becoming one of the global top 10 companies. Achieve stable profit growth with a shift to specialty EPS growth of around 10%/year Transition to a End in profit global food Get out of the red Accelerate company growth mome

  10. Slide 10: II. GROW: Accelerate Growth Momentum - Consumer Foods

    II. GROW: Accelerate Growth Momentum Consumer Foods (1) Domestic Food Products (2) Overseas Food Products Copyright © 2014 Ajinomoto Co., Inc. All rights reserved.

  11. Slide 11: Domestic Seasonings and Processed Foods

    GROW: Accelerate Growth Momentum (Consumer Foods) (1)Domestic Seasonings and Processed Foods Sales trends after the consumption tax rate increase Home-use: Impact of the last-minute surge in demand before the consumption tax rate increase ended in the first quarter and sales increased YoY from July.

  12. Slide 12: Nationwide launch of Toss Sala

    GROW: Accelerate Growth Momentum (Consumer Foods) (1) Domestic Seasonings and Processed Foods Shift to specialty businesses using our ability to create value for customers. New home-use product from autumn 2014 Nationwide launch of Toss Sala® Developed product by collecting ideas from working women

  13. Slide 13: Knorr Cup Soup with 40% reduced sodium

    GROW: Accelerate Growth Momentum (Consumer Foods) (1) Domestic Seasonings and Processed Foods Shift to specialty businesses using our ability to create value for customers. New home-use products from autumn 2014 Knorr® Cup Soup with 40% reduced sodium Reducing salt usually also reduces thickness and

  14. Slide 14: Domestic Food Products: Frozen Foods - Interim FY2014

    GROW: Accelerate Growth Momentum (Consumer Foods) (1) Domestic Food Products: Frozen Foods Review of interim FY2014 Sales increased and income decreased in interim FY2014. Basically in line with initial forecast because interim plan incorporated increase in raw material prices, etc. Continued strong

  15. Slide 15: Frozen Foods: Measures to restore profitability in FY2014

    GROW: Accelerate Growth Momentum (Consumer Foods) (1) Domestic Food Products: Frozen Foods Status of measures to restore profitability in FY2014 Working to further expand domestic and overseas sales and further reinforce the earnings structure. Forecast operating income of approximately ¥ 6.5 billio

  16. Slide 16: Frozen Foods: Measures for second half operating income plan

    GROW: Accelerate Growth Momentum (Consumer Foods) (1) Domestic Food Products: Frozen Foods Measures to achieve operating income plan for the second half of FY2014 Get back on a growth track by promoting continued expansion of domestic and overseas sales and further reinforcement of the earnings stru

  17. Slide 17: Overseas Food Products: Five Stars

    GROW: Accelerate Growth Momentum (Consumer Foods) (2) Overseas Food Products Create country/area pillars to follow Japan with rapid growth originating in the core “Five Stars” countries where the Ajinomoto Group does business outside Japan. “Five Stars” Aim for Doubling/Tripling Growth: Average 10%

  18. Slide 18: Overseas Food Products: Rising Stars

    GROW: Accelerate Growth Momentum (Consumer Foods) (2) Overseas Food Products Accelerate the creation of a foundation for rapid growth in the “Rising Stars.” Core initiatives for “Rising Stars” Africa/Middle East Europe/North America  Rollout umami seasoning AJI-NO-MOTO®  Strengthen product potenti

  19. Slide 19: Overseas Food Products: Objectives after merger of Windsor

    GROW: Accelerate Growth Momentum (Consumer Foods) (2) Overseas Food Products Objectives after merger of Windsor Achieve sales of ¥100 billion in the North American frozen food business by FY2020 and establish the Ajinomoto Group as the clear No. 1 manufacturer in the Japanese/Asian1 frozen food cate

  20. Slide 20: Process for integration of Windsor

    GROW: Accelerate Growth Momentum (Consumer Foods) (2) Overseas Food Products Process for integration of Windsor We have begun examining how to promote integration in stages after the closing. Nov. 5 PMI* Day 100 After PMI Day 100 Expand share in a Formulate FY2015 Formulate medium- growing market pl

  21. Slide 21: III. FIT: Further Business Structure Reinforcement

    III. FIT: Further Business Structure Reinforcement Technology for Fermentation Using Fewer Resources Copyright © 2014 Ajinomoto Co., Inc. All rights reserved.

  22. Slide 22: Progress of Fermentation Technology Using Fewer Resources

    FIT: Further Business Structure Reinforcement Progress of Fermentation Technology Using Fewer Resources (R&D Leadership) Achieve ¥3.0 Billion in Cost Reductions in FY2014. FY2011-2013 FY2014 FY2015 FY2016 Introduced in Brazil High performance (FY13/Q1) (Higher reduction rate) ★ Rollout to other regi

  23. Slide 23: IV. FY2014 Financial Strategy

    IV. FY2014 Financial Strategy Copyright © 2014 Ajinomoto Co., Inc. All rights reserved.

  24. Slide 24: FY2014 Financial Strategy

    FY2014 Financial Strategy Investments for Growth and Shareholder Returns: Further increase shareholder value. Increase year-end dividend by ¥2 (¥10 → ¥12; full-year dividends ¥20 → ¥22) for a forecast payout ratio of approximately 30%. Generate Free Cash Flow Weighted Allocation toward Investments f

  25. Slide 25: V. Animal Nutrition Business

    V. Animal Nutrition Business Market Environment and Progress of Structural Reform in FY2014 November 10, 2014 Yoichiro Togashi, President Ajinomoto Animal Nutrition Group, Inc. Copyright © 2014 Ajinomoto Co., Inc. All rights reserved.

  26. Slide 26: Structural Reform of Animal Nutrition Business: Market Environment

    Structural Reform of Animal Nutrition Business Market Environment FY2014 FY2014 Most recent Assumptions Forecast Spread (USD/ST) Approx. 230 Approx. 230 Approx. 210 YoY Lysine +5% +5% Market Threonine +5% +5% Growth Tryptophan +35% +60% Interim FY2014 Review Outlook Commodity Lysine/ Production adju

  27. Slide 27: Structural Reform of Animal Nutrition Business: Progress

    Structural Reform of Animal Nutrition Business Progress of Structural Reform (1) Expand specialty businesses (2) Strengthen competitiveness of Reduce volatility commodity businesses (1) Expand specialty businesses (2) Strengthen competitiveness of  AjiPro®-L commodity businesses ・ Introduce second-

  28. Slide 28: Measures to Strengthen the Flexible Production System

    Structural Reform of Animal Nutrition Business Measures to Strengthen the Flexible Production System (Ex.) New production system under Maximum variability in volume consideration for European plant (Current) → (New system) Lysine リジン 4% → 10% Threonine スレオニン 45% → 50% Reconfigurable operation トリプトファ

  29. Slide 29: Animal Nutrition: FY2014 Results and Forecast

    Structural Reform of Animal Nutrition Business FY2014 Results and Forecast Cumulative Quarter Operating Income Plan 5.1 ○ Specialty products (¥ Billion) ratio: 40% or higher 4.0 for the full year 0.2 Lysine price -1.3 -1.1 1Q 2Q 3Q + 4Q FY2014 ○ Increases in second quarter will continue (Results) (R

  30. Slide 30: VI. Pharmaceuticals Business FY2014 Strategy

    VI. Pharmaceuticals Business FY2014 Strategy November 10, 2014 Takashi Nagamachi President & CEO AJINOMOTO PHARMACEUTICALS CO., LTD. Copyright © 2014 Ajinomoto Co., Inc. All rights reserved.

  31. Slide 31: Interim FY2014 results

    Pharmaceuticals Business FY2014 Strategy Specific Initiatives for FY2014 1) Interim FY2014 results (¥ Billion) 1H FY2013 1H FY2014 2H FY2014 FY2014 YoY Change Full-year Results Results Forecast Forecast Net sales 27.9 18.8 -9.1 22.1 40.9 Gross profit 16.2 12.5 -3.7 15.0 27.4 Gross profit ratio 58.1%

  32. Slide 32: FY2014-2016 Medium-Term Management Plan Basic Policy

    Pharmaceuticals Business FY2014 Strategy Specific Initiatives for FY2014 2) FY2014-2016 Medium-Term Management Plan Basic Policy Amid expansion of the Ajinomoto Group’s food and health domains, handle specialized functions for business expansion in pharmaceuticals and peripheral domains Problem- sol

  33. Slide 33: Conduct thorough structural reform

    Pharmaceuticals Business FY2014 Strategy Specific Initiatives for FY2014 3) Conduct thorough structural reform Revise the functions and right-size the organizations and employees of AJINOMOTO PHARMACEUTICALS CO., LTD. Restructure R&D functions Restructuring to modulate functions Research Institute s

  34. Slide 34: Strengthen products/pipeline [1]

    Pharmaceuticals Business FY2014 Strategy Specific Initiatives for FY2014 4) Strengthen products/pipeline [1] Nutritional Drug Ulcerative Crohn’s therapy therapy The world’s first colitis disease marketing 14 2.5 Severe AJM300 Post-AJM300 (2018 launch) The Japan’s first 42 5.5 Moderate Elental® marke

  35. Slide 35: Strengthen products/pipeline [2]: Three measures

    Pharmaceuticals Business FY2014 Strategy Specific Initiatives for FY2014 4) Strengthen products/pipeline [2] - Three measures and outlook - 1. In-house development Three measures ・AJG511: Start of Phase III in 2H FY2014 (launch planned for 2017) (Steroid rectal foam for ulcerative colitis) Proactive

  36. Slide 36: Reference: Assumptions of FY2014 Forecast

    Reference Assumptions of FY2014 Forecast

  37. Slide 37: Assumptions of FY2014 Forecast

    【Reference】 Assumptions of FY2014 Forecast Foreign exchange rates (vs JPY) Feed-use amino acids 1) Estimated market size (Thousand MT) Sensitivity of translation effects to FY2012 FY2013 FY2014 (Forecast) Avg. rate full year O.P. Lysine 1,950 2,100 around 2,200 USD 100.0 ±¥1→ approx. ¥50 million Thr

  38. Slide 38: Eat Well, Live Well. AJINOMOTO.

    Eat Well, Live Well. AJINOMOTO. » Forward-looking statements, such as business performance forecasts, made in these materials are based on management’s estimates, assumptions and projections at the time of publication. A number of factors could cause actual results to differ materially from expectat

  39. Slide 39: FY2014 Forecast by Segments

    (Appendix) Nov.6, 2014 FY2014 Forecast by Segments (¥ Billion) A B A-B C A-C D E D-E A-D C-E (A-D)-(C-E) FY2014 FY2014 2H-FY14 FY2013 YoY Interim Interim YoY 2H-FY13 YoY Domestic Food Products Revised Initial Difference Revised Reasons for Forecast Revision or YoY Change of 2H Results Change FY2014

  40. Slide 40: FY2014 Forecast by Segments: Pharmaceuticals

    (¥ Billion) A B A-B C A-C D E D-E A-D C-E (A-D)-(C-E) FY2014 FY2014 2H-FY14 FY2013 YoY Interim Interim YoY 2H-FY13 YoY Pharmaceuticals Revised Initial Difference Revised Reasons for Forecast Revision or YoY Change of 2H Results Change FY2014 FY2013 Change Results Change Forecast Forecast Forecast Ne

Ajinomoto — Q2 FY2014 Earnings Presentation on 6ix